Making innovation real in the lives of everyday people is a Drexel founding principle, and a new research consortium between the University and one of the world’s top children’s hospitals will help make that goal a reality for young patients.
In November, the Children’s Hospital of Philadelphia, Drexel University and Hebrew University’s School of Pharmacy in Jerusalem entered into a partnership to bring pediatric therapies from the lab to the bedside, with an emphasis on medical innovations related to genetics and genomics.
One of the consortium’s first acts was a conference in Philadelphia in January where investigators from the three institutions met with potential collaborators to educate interested funders about the potential for discovery that the consortium offers.
